{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-005793","form_type":"8-K","ticker":"SABS","cik":"0001833214","company_name":"SAB Biotherapeutics, Inc.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.840719+00:00","generated_at":"2026-06-06T21:26:28.253358+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"SAB Biotherapeutics posts updated corporate presentation; no material news in filing","bullets":["Filing announces availability of an updated corporate presentation on company website.","No financial results, guidance changes, or specific operational updates disclosed in the 8-K.","Presentation is furnished under Regulation FD and not incorporated by reference.","Tickers SABS and SABSW trade on Nasdaq; no news affecting them directly."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-005793","json":"https://secwatch.observer/filing/0000950170-24-005793.json","markdown":"https://secwatch.observer/filing/0000950170-24-005793.md","text":"https://secwatch.observer/filing/0000950170-24-005793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024005793/0000950170-24-005793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024005793/sabs-20240119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:26:28.253358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}